Investigating the role of pain-modulating pathway genes in musculoskeletal pain
Investigating the role of pain-modulating pathway genes in musculoskeletal pain
Aims: the aim of this study was to determine if genetic variation in the pain-modulating gene DREAM and its pathway genes influence susceptibility to reporting musculoskeletal pain in the population.
Methods: pairwise tag single nucleotide polymorphisms (SNPs) in DREAM, PDYN and OPRK1 were genotyped in a UK population-based discovery cohort in whom pain was assessed using blank body manikins at three time points. Depression and anxiety symptoms were assessed at the first time point. Zero-inflated negative binomial regression was used to test for association between SNPs and the maximum number of pain sites reported (0–29) across the three time points. Significantly associated SNPs (p < 0.05) were subsequently genotyped for validation in a cohort of European men with pain assessed at two time points.
Results: thirty-five SNPs were genotyped in 1055 subjects, of whom 83% reported pain, in the discovery cohort. SNPs in each gene were associated with the maximum number of pain sites reported, were independent of symptoms of anxiety and depression and had a significant cumulative effect (p = 7.0 × 10−5). Significantly associated SNPs were successfully genotyped in 1733 men, 76% of whom reported pain, in the validation cohort, but did not show significant association with the number of pain sites.
Conclusions: genetic variation in the DREAM pathway genes was associated with the extent of pain reporting in a population-based cohort. These findings were not replicated in a single independent cohort; however, given the potential of this pathway as a therapeutic target, further investigation in additional cohorts is warranted.
28-34
Holliday, K.L.
58c01428-143a-4fc8-bd97-eb513573a697
McBeth, J.
98012716-66ba-480b-9e43-ac53b51dce61
MacFarlane, G.
dafa2d7d-c3c2-4c41-8fe7-e8d8de0ee3e7
Huhtaniemi, I.T.
44b7325c-b07b-43c2-8637-a815cb437f0b
Bartfai, G.
fe863ca6-a92f-49a7-b381-0780b750a47c
Casanueva, F.F.
a78fbfbf-9f03-4f71-ad84-607a5c86f5c4
Forti, G.
773d94d6-5386-49ef-800d-450b304fa340
Kula, K.
c3ed513e-a509-4a1f-96f2-5f2bf9765a40
Punab, M.
82034cd3-6df3-4feb-b6b3-791c0f887a60
Vanderschueren, D.
de49cace-a8d0-4ca0-bc39-274b55506a68
Wu, F.C.
462c5231-d570-47a4-a848-bcfda3a874e9
Thomson, W.
1e15e3f0-5128-496d-a2bd-da122d42ddfa
January 2013
Holliday, K.L.
58c01428-143a-4fc8-bd97-eb513573a697
McBeth, J.
98012716-66ba-480b-9e43-ac53b51dce61
MacFarlane, G.
dafa2d7d-c3c2-4c41-8fe7-e8d8de0ee3e7
Huhtaniemi, I.T.
44b7325c-b07b-43c2-8637-a815cb437f0b
Bartfai, G.
fe863ca6-a92f-49a7-b381-0780b750a47c
Casanueva, F.F.
a78fbfbf-9f03-4f71-ad84-607a5c86f5c4
Forti, G.
773d94d6-5386-49ef-800d-450b304fa340
Kula, K.
c3ed513e-a509-4a1f-96f2-5f2bf9765a40
Punab, M.
82034cd3-6df3-4feb-b6b3-791c0f887a60
Vanderschueren, D.
de49cace-a8d0-4ca0-bc39-274b55506a68
Wu, F.C.
462c5231-d570-47a4-a848-bcfda3a874e9
Thomson, W.
1e15e3f0-5128-496d-a2bd-da122d42ddfa
Holliday, K.L., McBeth, J., MacFarlane, G., Huhtaniemi, I.T., Bartfai, G., Casanueva, F.F., Forti, G., Kula, K., Punab, M., Vanderschueren, D., Wu, F.C. and Thomson, W.
(2013)
Investigating the role of pain-modulating pathway genes in musculoskeletal pain.
European Journal of Pain (United Kingdom), 17 (1), .
(doi:10.1002/j.1532-2149.2012.00163.x).
Abstract
Aims: the aim of this study was to determine if genetic variation in the pain-modulating gene DREAM and its pathway genes influence susceptibility to reporting musculoskeletal pain in the population.
Methods: pairwise tag single nucleotide polymorphisms (SNPs) in DREAM, PDYN and OPRK1 were genotyped in a UK population-based discovery cohort in whom pain was assessed using blank body manikins at three time points. Depression and anxiety symptoms were assessed at the first time point. Zero-inflated negative binomial regression was used to test for association between SNPs and the maximum number of pain sites reported (0–29) across the three time points. Significantly associated SNPs (p < 0.05) were subsequently genotyped for validation in a cohort of European men with pain assessed at two time points.
Results: thirty-five SNPs were genotyped in 1055 subjects, of whom 83% reported pain, in the discovery cohort. SNPs in each gene were associated with the maximum number of pain sites reported, were independent of symptoms of anxiety and depression and had a significant cumulative effect (p = 7.0 × 10−5). Significantly associated SNPs were successfully genotyped in 1733 men, 76% of whom reported pain, in the validation cohort, but did not show significant association with the number of pain sites.
Conclusions: genetic variation in the DREAM pathway genes was associated with the extent of pain reporting in a population-based cohort. These findings were not replicated in a single independent cohort; however, given the potential of this pathway as a therapeutic target, further investigation in additional cohorts is warranted.
This record has no associated files available for download.
More information
Accepted/In Press date: 2 April 2012
e-pub ahead of print date: 21 June 2012
Published date: January 2013
Identifiers
Local EPrints ID: 491254
URI: http://eprints.soton.ac.uk/id/eprint/491254
ISSN: 1090-3801
PURE UUID: b1ab6832-91b0-4ff9-b60c-b5d780874737
Catalogue record
Date deposited: 18 Jun 2024 16:48
Last modified: 19 Jun 2024 02:10
Export record
Altmetrics
Contributors
Author:
K.L. Holliday
Author:
J. McBeth
Author:
G. MacFarlane
Author:
I.T. Huhtaniemi
Author:
G. Bartfai
Author:
F.F. Casanueva
Author:
G. Forti
Author:
K. Kula
Author:
M. Punab
Author:
D. Vanderschueren
Author:
F.C. Wu
Author:
W. Thomson
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics